Jasper Therapeutics, Inc. Share Price
NASDAQ: JSPR | Micro CapJasper Therapeutics, Inc. Stock Performance
Jasper Therapeutics, Inc. Share Price Today
As of 29 October 2026, Jasper Therapeutics, Inc.'s share price is $0.53. The stock opened at $0.56, compared to its previous close of $0.52. During today's trading session, Jasper Therapeutics, Inc.'s share price traded between $0.53 and $0.56, with an average price of $0.54. Over the past 52 weeks, the stock has recorded a high of $2.51 and a low of $0.32. In terms of performance, Jasper Therapeutics, Inc.'s share price has declined by 43.36% over the last six months and is down 76.64% on a year-on-year basis.
Jasper Therapeutics, Inc. Share Price Chart
Jasper Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Jasper Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Jasper Therapeutics, Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.
Jasper Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $0.61 | $0.53 | -8.98% |
Sep 2026 | $0.70 | $0.58 | -17.40% |
Aug 2026 | $0.61 | $0.70 | +10.92% |
Jul 2026 | $0.41 | $0.63 | +48.36% |
Jun 2026 | $0.85 | $0.43 | -49.47% |
May 2026 | $0.93 | $0.84 | -9.55% |
Apr 2026 | $0.89 | $0.93 | +7.25% |
Mar 2026 | $1.33 | $0.87 | -37.03% |
Feb 2026 | $1.48 | $1.38 | -5.80% |
Jan 2026 | $1.83 | $1.47 | -19.51% |
Dec 2025 | $1.80 | $1.82 | +0.00% |
Nov 2025 | $2.09 | $1.82 | -19.47% |